Aflac Cancer — Foreign currency translation decreased by 157.7% to -$750.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 134.2%, from $2.19B to -$750.00M.
Positive values indicate a favorable currency impact, while negative values indicate a drag on reported financial results due to currency depreciation.
The impact of fluctuations in foreign exchange rates on the valuation of liabilities and assets within the cancer insura...
Standard 'Foreign Currency Translation Adjustment' (FCTA) reported by multinational insurers.
afl_segment_cancer_foreign_currency_translation| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$1.59B | -$1.59B | -$1.59B | -$1.90B | -$1.90B | -$1.90B | -$1.90B | -$295.00M | -$3.71B | -$1.33B | -$2.76B | -$2.44B | -$4.11B | $2.19B | $1.30B | -$750.00M |
| QoQ Change | — | +0.0% | +0.0% | -18.9% | +0.0% | +0.0% | +0.0% | +84.4% | <-999% | +64.2% | -107.8% | +11.7% | -68.7% | +153.3% | -40.7% | -157.7% |
| YoY Change | — | — | — | — | -18.9% | -18.9% | -18.9% | +84.4% | -95.4% | +30.0% | -834.6% | +34.3% | — | +179.5% | +153.3% | -134.2% |